Skip to content
10-Q

Quarterly Report

KRAIG BIOCRAFT LABORATORIES, INC. KBLB

0001493152-23-016671

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 12, 2023 1.03B sh
Current Liabilities Q1 2023 · Mar 31, 2023 $8.19M
Current Liabilities Q1 2023 · Dec 31, 2022 $8.07M
Total Liabilities Q1 2023 · Mar 31, 2023 $8.2M
Total Liabilities Q1 2023 · Dec 31, 2022 $8.09M
Current Assets Q1 2023 · Mar 31, 2023 $3.56M
Current Assets Q1 2023 · Dec 31, 2022 $3.98M
Total Assets Q1 2023 · Mar 31, 2023 $4.16M
Total Assets Q1 2023 · Dec 31, 2022 $4.57M
Stock Issued Q1 2023 · Feb 16, 2023 2.43M sh
Stock Issued Q1 2023 · Feb 15, 2022 7.4M sh
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$479.32K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$4.1M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$5.3M
Eps Basic Q1 2023 · Mar 31, 2022 $0.00
Sga Expense Q1 2023 · Mar 31, 2022 $213.02K
Rd Expense Q1 2023 · Mar 31, 2022 $27.5K
Net Income Q1 2023 · Mar 31, 2022 −$1.05M
Operating Income Q1 2023 · Mar 31, 2022 −$545.71K